Fresenius SE & Co. KGaA is a global healthcare group that specializes in providing a wide range of medical products and services. With a focus on personalized tumor medicine and innovative therapies, the company aims to improve patient care and outcomes. They offer biosimilars, infusion and nutrition systems, clinical nutrition, transfusion medicine, and cell therapies, among other fields of work. Fresenius also operates inpatient and outpatient treatments, occupational healthcare, prevention, rehabilitation, and health tourism. Committed to sustainability, the company prioritizes access to healthcare, patient and product safety, employee diversity and equal opportunities, human rights, and environmental protection.
As Europe's leading private healthcare provider, Fresenius serves chronically and critically ill patients with a range of products and services. They have a strong focus on digitalization to enhance oncology patient care and streamline the patient journey. The company has successfully completed divestment of fertility services group Eugin and launched a generic drug for the treatment of serious fungal infections in the U.S. Additionally, Fresenius has signed the Zero Health Gaps Pledge to promote equal opportunities in healthcare. With a commitment to innovation and sustainability, Fresenius continues to make significant contributions to the healthcare industry.
Generated from the website